Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

RICHIES SPECIALTY PHARMACY — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

RICHIES SPECIALTY PHARMACY

via ATLANTIC STRATEGIES GROUP LLC

1st Quarter (Jan 1 - Mar 31) · 2016Posted Apr 18, 2016Filing document ↗LDA record ↗

Income$5Kfee reported

Client

Name: RICHIES SPECIALTY PHARMACY
Description: pharmaceutical compounding company
Location: Texas · United States of America

Registrant

Firm: ATLANTIC STRATEGIES GROUP LLC
Description: Government relations firm
Location: Washington D.C., District of Columbia, United States of America

Lobbying activities

1 issue

Defense
Worked with Congress to address specific compounding pharmacy policies within DOD's TRICARE program.
LobbyistsHELEN C SIRACUSE
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.